Solid organ transplantation in patients with HIV infection

Transplantation

Volumn 72, Issue 2, 2001, Pages 177-181

  Gow, Paul J ^a   Pillay, Deenan ^b   Mutimer, David ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ADEFOVIR; ANTIRETROVIRUS AGENT; EFAVIRENZ; HEPATITIS B ANTIBODY; INTERFERON; LAMIVUDINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RIBAVIRIN; ZIDOVUDINE;

CLINICAL TRIAL; GASTROINTESTINAL TOXICITY; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0034902851     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200107270-00001     Document Type: Review

References (43)

1. Should all human immunodeficiency virus-infected patients with end-stage renal disease be excluded from transplantation? The views of U.S transplant centers
2. HIV infection and the kidney
3. Impact of chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIV-infected drug users
4. Sero-surveillance of transmissible hepatitis B & C viruses in asymptomatic HIV infection in haemophiliacs
5. Prevalence of hepatitis C virus antibodies among patients infected with human immunodeficiency virus
6. Hepatitis C in the patient with human immunodeficiency virus infection
7. Hepatitis C, and HIV infection: Biological, clinical, and therapeutic implications
8. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis
9. Influence of human immunodeficiency virus type I infection on the natural course of chronic parenterally acquired hepatitis C
10. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients
11. Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: An early report
12. Efficacy and safety of combination therapy with interferon-alpha2b and ribavirin for chronic hepatitis C in HIV-infected patients
13. Management of chronic hepatitis C in HIV-infected patients
14. The influence of human immunodeficiency virus type 1 infection on the development of the hepatitis B virus carrier state
15. The interaction of human immunodeficiency virus infection and hepatitis B virus infection in infected homosexual men
16. Human immunodeficiency virus infection does not alter serum transaminases and hepatitis B virus (HBV) DNA in homosexual patients with chronic HBV infection
17. Infection with human immunodeficiency virus in the Pittsburgh transplant population. A study of 583 donors and 1043 recipients, 1981-1986
18. Transplantation in HIV+ patients
19. An observational study of 11 French liver transplant recipients infected with human immunodeficiency virus type 1
20. Liver transplantation in a hemophilia patient with acquired immunodeficiency syndrome
21. Outcome of orthotopic liver transplantation in patients with haemophilia
22. Liver transplantation for chronic hepatitis B infection with the use of combination lamivudine and low-dose hepatitis B immune globulin
23. Lamivudine therapy in patients undergoing liver transplantation for hepatitis B virus precore mutant-associated infection: High resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose hepatitis B immune globulin
24. Multicenter study of lamivudine therapy for hepatitis B after liver transplantation
25. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin
26. Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients
27. Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants
28. Pathogenesis of human immunodeficiency virus (HIV)-associated nephropathy
29. Resolution of HIV-associated nephrotic syndrome with highly active antiretroviral therapy delivered by gastrostomy tube
30. Maintenance hemodialysis in patients with HIV-associated nephropathy
31. Transmission of AIDS virus at renal transplantation
32. Human immunodeficiency virus transmission by organ donation. Outcome in cornea and kidney recipients
33. HIV infection in cadaveric renal allograft recipients in the North Italy transplant program
34. HIV infection after heart transplantation: A case report
35. HIV infection in the first heart transplantation in Italy: Fatal outcome. Case report
36. Human immunodeficieney virus infection in patients with solid-organ transplants: Report of five cases and review
37. AIDS across Europe, 1994-1998; the EuroSIDA study
38. Protease inhibitors as inhibitors of human cytochromes P450: High risk associated with ritonavir
39. Concomitant human immunodeficiency virus protease inhibitor therapy markedly reduces tacrolimus metabolism and increases blood levels
40. Interaction between nelfinavir and tacrolimus after orthoptic liver transplantation in a patient coinfected with HIV and hepatitis C virus (HCV)
41. Abacavir and mycophenelic acid, an inhibitor of inosine monophosphate dehydrogenase, have profound and synergistic anti-HIV activity
42. The novel immunosuppressive agent mycophenolate mofetil markedly potentiates the antiherpesvirus activities of acyclovir, ganciclovir, and penciclovir in vitro and in vivo
43. Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo